Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
French nuclear testing in Pacific slightly raised cancer rates in Polynesia
Residents of French Polynesia have higher rates of thyroid cancer than would have occurred without…
RANZCR welcomes Medicare funding for game-changing breast marker clips
The Royal Australian and New Zealand College of Radiologists (RANZCR) is excited to confirm that…
Researchers trace evolution of contagious cancers affecting tasmanian devils
Transmissible cancers, which occur only rarely in the animal kingdom, are spread by the transfer…
Researchers map genetic signature of precursor to liver cancer
- AACR 2023: Novel allogeneic CAR T cell therapy delivers promising early results in metastatic clear cell renal cell carcinoma
- Src heterodimerically activates lyn or fyn to serve as targets for oesophageal squamous cell carcinoma diagnosis and treatment
- Saudi Arabia has a higher than global average of respondents who never took colorectal cancer test
Proton therapy for prostate cancer: does the evidence support the hype?
Stephen McMahon, Queen’s University Belfast High energy proton beam therapy, an advanced form of radiotherapy, made its debut in the…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.